CN105663847A - 一种治疗精神分裂症的中药制剂及制备方法 - Google Patents
一种治疗精神分裂症的中药制剂及制备方法 Download PDFInfo
- Publication number
- CN105663847A CN105663847A CN201610128840.5A CN201610128840A CN105663847A CN 105663847 A CN105663847 A CN 105663847A CN 201610128840 A CN201610128840 A CN 201610128840A CN 105663847 A CN105663847 A CN 105663847A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- traditional chinese
- preparation
- times amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 238000002360 preparation method Methods 0.000 title claims abstract description 57
- 201000000980 schizophrenia Diseases 0.000 title abstract description 15
- 239000004615 ingredient Substances 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 210000003038 endothelium Anatomy 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000012153 distilled water Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000000243 solution Substances 0.000 claims description 6
- 241000345998 Calamus manan Species 0.000 claims description 4
- 241000282320 Panthera leo Species 0.000 claims description 4
- 241001604597 Pyrestini Species 0.000 claims description 4
- 241000921449 Rhodobryum roseum Species 0.000 claims description 4
- 241000657665 Rhopilema esculentum Species 0.000 claims description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 4
- 229910052737 gold Inorganic materials 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- 235000012950 rattan cane Nutrition 0.000 claims description 4
- -1 boil 2~3 hours Substances 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 208000024891 symptom Diseases 0.000 abstract description 26
- 230000000694 effects Effects 0.000 abstract description 16
- 210000004185 liver Anatomy 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 230000035922 thirst Effects 0.000 abstract description 9
- 210000003734 kidney Anatomy 0.000 abstract description 8
- 238000010791 quenching Methods 0.000 abstract description 7
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 abstract description 6
- 206010022437 insomnia Diseases 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 208000019901 Anxiety disease Diseases 0.000 abstract description 4
- 230000036506 anxiety Effects 0.000 abstract description 4
- 210000005036 nerve Anatomy 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 208000000044 Amnesia Diseases 0.000 abstract 1
- 208000031091 Amnestic disease Diseases 0.000 abstract 1
- 241001001015 Aristolochia mollis Species 0.000 abstract 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 abstract 1
- 235000017491 Bambusa tulda Nutrition 0.000 abstract 1
- 244000298479 Cichorium intybus Species 0.000 abstract 1
- 235000007542 Cichorium intybus Nutrition 0.000 abstract 1
- 244000276331 Citrus maxima Species 0.000 abstract 1
- 235000001759 Citrus maxima Nutrition 0.000 abstract 1
- 206010013954 Dysphoria Diseases 0.000 abstract 1
- 241001125671 Eretmochelys imbricata Species 0.000 abstract 1
- 241000209035 Ilex Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 240000002853 Nelumbo nucifera Species 0.000 abstract 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 abstract 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 abstract 1
- 244000061661 Orchis Species 0.000 abstract 1
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 abstract 1
- 241000206607 Porphyra umbilicalis Species 0.000 abstract 1
- 241000921453 Rhodobryum Species 0.000 abstract 1
- 241000220317 Rosa Species 0.000 abstract 1
- 241000242583 Scyphozoa Species 0.000 abstract 1
- 241000193241 Solanum dulcamara Species 0.000 abstract 1
- 235000010307 Solanum dulcamara var. dulcamara Nutrition 0.000 abstract 1
- 240000006064 Urena lobata Species 0.000 abstract 1
- 230000006986 amnesia Effects 0.000 abstract 1
- 239000011425 bamboo Substances 0.000 abstract 1
- 244000195896 dadap Species 0.000 abstract 1
- 230000000994 depressogenic effect Effects 0.000 abstract 1
- 238000011474 orchiectomy Methods 0.000 abstract 1
- 230000000171 quenching effect Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 208000004547 Hallucinations Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 208000001848 dysentery Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 206010019233 Headaches Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000008451 emotion Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000003340 mental effect Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 230000021317 sensory perception Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 206010012239 Delusion Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 4
- 230000006399 behavior Effects 0.000 description 4
- 208000002894 beriberi Diseases 0.000 description 4
- 231100000868 delusion Toxicity 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010034702 Persecutory delusion Diseases 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 206010043458 Thirst Diseases 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000003026 hypopharynx Anatomy 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000000698 schizophrenic effect Effects 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 239000002435 venom Substances 0.000 description 3
- 231100000611 venom Toxicity 0.000 description 3
- 210000001048 venom Anatomy 0.000 description 3
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 206010054196 Affect lability Diseases 0.000 description 2
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010029216 Nervousness Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003920 cognitive function Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 208000017194 Affective disease Diseases 0.000 description 1
- 206010002942 Apathy Diseases 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 235000014277 Clidemia hirta Nutrition 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 208000027691 Conduct disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 206010057315 Daydreaming Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012241 Delusion of grandeur Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000030814 Eating disease Diseases 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 208000019454 Feeding and Eating disease Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 206010054787 Haemorrhoidal haemorrhage Diseases 0.000 description 1
- 206010019072 Hallucination, olfactory Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000069219 Henriettea Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 208000019022 Mood disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 206010030302 Oliguria Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241000596297 Photis Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010037742 Rabies Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010067868 Skin mass Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000016571 aggressive behavior Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 229940124584 antitussives Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 208000035850 clinical syndrome Diseases 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 235000014632 disordered eating Nutrition 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 230000006397 emotional response Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000030136 gastric emptying Effects 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 208000010553 multiple abscesses Diseases 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- RAPZEAPATHNIPO-UHFFFAOYSA-N risperidone Chemical compound FC1=CC=C2C(C3CCN(CC3)CCC=3C(=O)N4CCCCC4=NC=3C)=NOC2=C1 RAPZEAPATHNIPO-UHFFFAOYSA-N 0.000 description 1
- 229960001534 risperidone Drugs 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/614—Cnidaria, e.g. sea anemones, corals, coral animals or jellyfish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/10—Bryophyta (mosses)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/59—Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗精神分裂症的中药制剂及制备方法,属中药领域;本发明中药制剂有效成分的原料组成为:玳瑁、梵天花、海蜇、岗梅根、回心草、海桐皮、荷叶、化橘红、黑藁本、菊苣、红门兰、鸡内金、苦茄、金狮藤、苦竹笋和紫菜;本发明中药制剂所选药材配伍相宜,符合中医药学和现代医药学理论,并具有强心补肾、安神解郁、生津止渴之功效,对治疗精神分裂症引起的心烦焦虑,失眠,健忘等症状具有独特疗效,且疗效显著,成本较低,治愈后不复发,安全可靠,无毒副作用,标本兼治,奇效实用,值得临床上广泛推广应用。
Description
所属技术领域
本发明涉及中药领域,尤其涉及一种治疗精神分裂症的中药制剂及制备方法。
背景技术
精神分裂症是一组病因未明的重性精神病,多在青壮年缓慢或亚急性起病,临床上往往表现为症状各异的综合征,涉及感知觉、思维、情感和行为等多方面的障碍以及精神活动的不协调。患者一般意识清楚,智能基本正常,但部分患者在疾病过程中会出现认知功能的损害。病程一般迁延,呈反复发作、加重或恶化,部分患者最终出现衰退和精神残疾,但有的患者经过治疗后可保持痊愈或基本痊愈状态。
精神分裂症是由一组症状群所组成的临床综合征,它是多因素的疾病。尽管目前对其病因的认识尚不很明确,但个体心理的易感素质和外部社会环境的不良因素对疾病的发生发展的作用已被大家所共识。无论是易感素质还是外部不良因素都可能通过内在生物学因素共同作用而导致疾病的发生,不同患者其发病的因素可能以某一方面较为重要。精神分裂症的临床症状复杂多样,可涉及感知觉、思维、情感、意志行为及认知功能等方面,个体之间症状差异很大,即使同一患者在不同阶段或病期也可能表现出不同症状。感知觉障碍:精神分裂症可出现多种感知觉障碍,最突出的感知觉障碍是幻觉,包括幻听、幻视、幻嗅、幻味及幻触等,而幻听最为常见。思维障碍:思维障碍是精神分裂症的核心症状,主要包括思维形式障碍和思维内容障碍。思维形式障碍是以思维联想过程障碍为主要表现的,包括思维联想活动过程、思维联想连贯性及逻辑性等方面的障碍。妄想是最常见、最重要的思维内容障碍。最常出现的妄想有被害妄想、关系妄想、影响妄想、嫉妒妄想、夸大妄想、非血统妄想等。据估计,高达80%的精神分裂症患者存在被害妄想,被害妄想可以表现为不同程度的不安全感,如被监视、被排斥、担心被投药或被谋杀等,在妄想影响下患者会做出防御或攻击性行为,此外,被动体验在部分患者身上也较为突出,对患者的思维、情感及行为产生影响。情感障碍:情感淡漠及情感反应不协调是精神分裂症患者最常见的情感症状,此外,不协调性兴奋、易激惹、抑郁及焦虑等情感症状也较常见。
目前,临床上治疗精神分裂症主要以中、西药治疗为主,西药大多对身体的副作用较大,容易形成成瘾性、耐药性,且易复发,而中药治疗具有安全无毒副作用,能够达到标本兼治的目的,值得各大医院广泛推广应用。
发明内容
本发明提供了一种治疗精神分裂症的中药制剂及制备方法;本发明中药制剂所选药材配伍相宜,符合中医药学和现代医药学理论,并具有强心补肾、安神解郁、生津止渴之功效,对治疗精神分裂症引起的心烦焦虑,失眠,健忘等症状具有独特疗效,且疗效显著,成本较低,治愈后不复发,安全可靠,无毒副作用,标本兼治,奇效实用,值得临床上广泛推广应用。
为实现上述目的,本发明的技术方案实施如下:
一种治疗精神分裂症的中药制剂,制成所述中药制剂有效成分的原料组成及重量份数为:
制成所述中药制剂有效成分的原料组成及重量份数为:
制成所述中药制剂有效成分的原料组成及重量份数为:
制成所述中药制剂有效成分的原料组成及重量份数为:
一种治疗精神分裂症的中药制剂的制备方法,包括以下工艺步骤:
(1)将玳瑁、梵天花、海蜇、岗梅根、回心草、荷叶、化橘红、菊苣、红门兰、苦茄、苦竹笋和紫菜洗净,放入容器内,加入8~10倍量的蒸馏水,浸泡5~6小时后,煮沸3~4小时,提取;再次加入6~8倍量蒸馏水,煮沸2~3小时,提取;最后,加入4~6倍量蒸馏水,加热煮沸1~2小时,提取;合并三次提取液,过滤,得滤液,备用;
(2)将海桐皮和黑藁本洗净,浸入6倍量的70%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,备用;
(3)将鸡内金和金狮藤放入容器内,进行粉碎处理,研末,得到过200目的细粉,备用;
(4)将上述步骤(1)~(3)所制得的滤液以及细粉加入10~12倍量的蒸馏水,搅拌溶解均匀后,加热煮沸0.5小时,静置1小时,提取过滤,得注射液,将注射液瓶装封存,即得所述的治疗精神分裂症的中药制剂。
本发明所用中药的药性如下:
玳瑁:味甘、咸,性寒;归心、肝经。平肝定惊,清热解毒。主热病高热,神昏谵语抽搐,小儿惊痫,眩晕,心烦失眠,痈肿疮毒。《纲目》载:“解痘毒,镇心神,急惊客忤,伤寒热结,狂言。”
梵天花:味甘、苦,性凉;归肝、大肠经。祛风利湿,消热解毒。主风湿痹痛,泄泻,痢疾,感冒,咽喉肿痛,肺热咳嗽,风毒流注,疮疡肿毒,跌打损伤,毒蛇咬伤。《广西实用中草药新选》载:“消炎消肿,凉血解毒。主治痢疾,腹泻,疖肿,狂犬病,毒蛇咬伤。”
海蜇:味咸,性平;归肝、肾、肺经。化痰热,散结降压。主治肺热咳嗽痰多,热病痰多神昏,中风痰涎壅盛,原发性高血压,瘰疬,丹毒。《医林纂要》载:“补心益肺,滋阴化痰,去结核,行邪湿,解渴醒酒,止嗽除烦。”
岗梅根:味苦、甘,性寒;归肺、肝、大肠经。清热生津,散瘀解毒。主感冒,头痛,眩晕,热病烦渴,痧气,热泻,肺痈,百日咳,咽喉肿痛,痔血,淋病,疔疮肿毒,跌打损伤。《南宁市药物志》载:“清热解毒,润肺止渴。治喉痛口渴,咳血,痧气。”
回心草:味淡、微苦,性平;归心经。养心安神,清肝明目。用于心悸怔忡,神经衰弱;外用治目赤肿痛。《云南思茅中草药选》载:“安神镇静。治心慌、心悸,心脏病。”
海桐皮:味苦,性平;归肝、肾经。祛风湿,舒筋通络。用于风湿麻木,腰腿筋骨疼痛,跌打损伤;外用治各种顽癣。《海药本草》载:“主腰脚不遂,顽痹腿膝疼痛,霍乱,赤白泻痢,血痢,疥癣。”
荷叶:味苦,性平;归肝、脾、胃经。清热解暑,升发清阳,凉血止血。用于暑热烦渴,暑湿泄泻,脾虚泄泻,血热吐衄,便血崩漏,降血压,降血脂。现代研究表明,荷叶有降血脂作用。
化橘红:味辛、苦,性温;归肺、脾经。散寒燥湿,利气消痰。用于风寒咳嗽,喉痒痰多,食积伤酒,呕恶痞闷。《纲目拾遗》载:“治痰症,消油腻、谷食积,醒酒,宽中,解蟹毒。”
黑藁本:味辛、苦,性温。散寒止痛。用于风寒感冒,头痛,偏头痛,神经性头痛,胃寒痛,肌肉关节痛。
菊苣:味苦,性寒。清肝利胆,健胃消食,清热解毒,利尿消肿。用于湿热黄疸,胃痛食少,水肿尿少。药理实验表明,野生菊苣的根可提高食欲,改善消化功能,高浓度的浸剂可增进胃分泌。
红门兰:味甘,性平;归心、肾、胃经。强心补肾,生津止渴,健脾胃。主治烦躁口渴,不思饮食,月经不调,虚劳贫血,头晕,眼花。《内蒙古中草药》载:“强心,补肾,生津,止渴,健脾胃,治烦躁口渴,不思饮食,阴液不足,月经不调。”
鸡内金:味甘,性寒;归脾、胃、小肠、膀胱经。消食健胃助消化,涩精止遗。可以促进胃液分泌,提高胃酸度及消化力,使胃运动功能明显增强,胃排空加快。《滇南本草》载:“宽中健脾,消食磨胃。治小儿乳食结滞,肚大筋青,痞积疳积。”
苦茄:味苦、辛,性寒。驱风除湿,清热解毒。主治风湿疼痛,破伤风,痈肿,恶疮,疥疮,外伤出血。《国药的药理学》载:“为利尿药,又为神经痛药及消肿药。”
金狮藤:味苦、辛;性微寒;归肝、胃、大肠经。清热解毒,收敛镇痛。用于中暑腹痛,胃痛,腹痛下痢,风湿关节痛,毒蛇咬伤,高血压病,皮肤湿疹。
苦竹笋:味苦,性寒。清热除烦,除湿利水。主热病烦渴,湿热黄疸,小便不利,脚气。《食医心镜》载:“理心烦闷,益气力,止渴,主消渴,利水道,下气,理风热,脚气,蒸煮食之。”
紫菜:味甘、咸,性寒;归肺、脾、膀胱经。化痰软坚,利咽止咳,养心除烦,利水除湿。主瘿瘤,脚气,水肿,咽喉肿痛,咳嗽,烦躁失眠,小便淋痛,泻痢。《随恳居饮食谱》载:“和血养心,清烦涤热,治不寐,利咽喉,除脚气瘿瘤,主时行泻痢,析醒开胃。”
本发明与现有技术相比,具有以下有益效果:
本发明中药制剂所选药材配伍相宜,符合中医药学和现代医药学理论,并具有强心补肾、安神解郁、生津止渴之功效,对治疗精神分裂症引起的心烦焦虑,失眠,健忘等症状具有独特疗效,且疗效显著,成本较低,治愈后不复发,安全可靠,无毒副作用,标本兼治,奇效实用,值得临床上广泛推广应用。
具体实施方式
下面结合具体实施例对本发明做进一步阐述。
实施例1
本发明中药制剂有效成分的原料组成及重量为:
一种治疗精神分裂症的中药制剂的制备方法,包括以下工艺步骤:
(1)将玳瑁、梵天花、海蜇、岗梅根、回心草、荷叶、化橘红、菊苣、红门兰、苦茄、苦竹笋和紫菜洗净,放入容器内,加入8~10倍量的蒸馏水,浸泡5~6小时后,煮沸3~4小时,提取;再次加入6~8倍量蒸馏水,煮沸2~3小时,提取;最后,加入4~6倍量蒸馏水,加热煮沸1~2小时,提取;合并三次提取液,过滤,得滤液,备用;
(2)将海桐皮和黑藁本洗净,浸入6倍量的70%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,备用;
(3)将鸡内金和金狮藤放入容器内,进行粉碎处理,研末,得到过200目的细粉,备用;
(4)将上述步骤(1)~(3)所制得的滤液以及细粉加入10~12倍量的蒸馏水,搅拌溶解均匀后,加热煮沸0.5小时,静置1小时,提取过滤,得注射液,将注射液瓶装封存,即得所述的治疗精神分裂症的中药制剂。
用法用量:静脉注射5mg,以25%葡萄糖液稀释后在1~2分钟内缓慢注入,每日2次,早晚各1次,5天为1个疗程,2~3个疗程即可痊愈,病情严重者遵医嘱酌增用量。
实施例2
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
实施例3
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
实施例4
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
实施例5
本发明中药制剂有效成分的原料组成及重量为:
本实施例的中药制剂制备方法工艺步骤及用法用量与实施例1相同。
临床资料:
1、病例选择:
作为治疗精神分裂症的中药制剂,选择确诊的精神分裂症患者210例临床观察,病人随机分成治疗组和对照组两组,治疗组105例,其中男性,52例,女性53例,年龄25~60岁,平均年龄42.5岁,平均病程2年;对照组105例,其中男性53例,女性52例,年龄24~61岁,平均年龄42.5岁,平均病程2年。
治疗组和对照组两组病例的病程、症状轻重程度基本一致,无显著差异,具有可比性。
2、药物选择:
治疗组使用本发明中药制剂,静脉注射5mg,以25%葡萄糖液稀释后在1~2分钟内缓慢注入,每日2次,早晚各1次,5天为1个疗程,2~3个疗程即可痊愈,病情严重者遵医嘱酌增用量。
对照组服用利培酮片,建议起始剂量为每次0.5mg,每日2次,剂量可根据个体需要进行调整,剂量增加的幅度可为每次0.5mg,每日2次,直至一次1-2mg,每日2次。
3、疗效判定:
(1)治愈:临床症状全部消失,思维较正常,情绪稳定,社会功能恢复正常。
(2)显效:临床症状明显改善,思维较正常,情绪稳定,社会功能明显恢复。
(3)有效:临床症状有所改善,思维较正常,情绪稳定,社会功能有所恢复。
(4)无效:通过治疗后临床症状无改善,无自知力。
4、结果:
以上结果显示,治疗组的治愈率和总有效率明显高于对照组。
典型病例举例:
1、雷某,女,26岁,重庆永川区人。患者猜疑,思维混乱,言语文字难以理解,情绪不稳定,饮食紊乱,闭门不出,不修边幅,行为退缩,孤独不群,不能有效工作学习,生活不能自理,人际关系紧张,不承认自已有病等症状,家人带其去医院就诊,诊断为精神分裂症,医生给予本发明中药制剂治疗,使用1个疗程后,精神明显稳定很多,继续使用1个疗程后,精神恢复正常,痊愈,随访至今未复发。
2、钱某,男,30岁,江苏无锡人。患者患病时一直觉得有人要害他,别人的一个眼神,一个动作对他都是一种暗示,准备向他发起进攻,患者整天被虚幻的想法所恐慌后,家人把他送进某精神病医院,医生判断为精神分裂症,使用西药治疗,治疗效果不理想,后来我院就诊,医生给予本发明中药制剂治疗,使用1个疗程后,不正常的症状明显减轻,继续使用2个疗程后,不正常的症状消失,痊愈,2年后随访已和正常人一样,症状未再复发过。
3、汤某,女,51岁,福建宁德人。患者突然兴奋、冲动,言语凌乱,行为紊乱,片断幻觉和妄想,家人带去医院就诊,医生确诊为精神分裂症,患者用过多种方法治疗,未见奇效,经医生介绍,给予本发明中药制剂治疗,使用1个疗程后,症状有所好转,使用3个疗程后,精神恢复正常,1年后随访无复发。
4、尹某,男,29岁,广东韶关人。患者精神容易兴奋或疲乏,情绪上烦躁,往往出现失眠、无力、头痛、迟钝、注意力不集中、学习工作能力不足等表现,家人把他送进某精神病医院,医生判断为精神分裂症前兆。医生建议使用本发明中药制剂治疗,使用1个疗程后,上述症状明显缓解,继续使用2个疗程后,症状全部消失,食欲振作,工作精力旺盛。
5、黎某,女,45岁,安徽宿州人。患者失眠、头痛、头晕、无力、情绪不稳等不适感及神经症症状,去某医院就诊,确诊为精神分裂症,医生建议使用本发明中药制剂治疗,使用1个疗程后,上述症状有所好转,情绪稍微稳定,使用2个疗程后,上述症状消失,情绪稳定,痊愈,半年后随访未复发。
6、易某,男,35岁,四川雅安人。患者情绪极其不稳定,经常打骂家人,睡眠较差,经常半夜起来又哭又骂,有时说话东拉西扯,不知其所云,患者并经常诉头晕头疼,家人后带其于某医院就诊,确诊为精神分裂症,医生给予本发明中药制剂治疗,使用1个疗程后,症状有所好转,使用2个疗程后,症状全部消失,身体恢复正常,痊愈,1年后随访无复发。
Claims (5)
1.一种治疗精神分裂症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
2.根据权利要求1所述的一种治疗精神分裂症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
3.根据权利要求1所述的一种治疗精神分裂症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
4.根据权利要求1所述的一种治疗精神分裂症的中药制剂,其特征在于:制成所述中药制剂有效成分的原料组成及重量份数为:
5.一种如权利要求1~4任一项所述治疗精神分裂症的中药制剂的制备方法,其特征在于:包括以下工艺步骤:
(1)将玳瑁、梵天花、海蜇、岗梅根、回心草、荷叶、化橘红、菊苣、红门兰、苦茄、苦竹笋和紫菜洗净,放入容器内,加入8~10倍量的蒸馏水,浸泡5~6小时后,煮沸3~4小时,提取;再次加入6~8倍量蒸馏水,煮沸2~3小时,提取;最后,加入4~6倍量蒸馏水,加热煮沸1~2小时,提取;合并三次提取液,过滤,得滤液,备用;
(2)将海桐皮和黑藁本洗净,浸入6倍量的70%的乙醇溶液浸泡1~2小时,加热提取3小时,回收乙醇,滤过,得滤液,备用;
(3)将鸡内金和金狮藤放入容器内,进行粉碎处理,研末,得到过200目的细粉,备用;
(4)将上述步骤(1)~(3)所制得的滤液以及细粉加入10~12倍量的蒸馏水,搅拌溶解均匀后,加热煮沸0.5小时,静置1小时,提取过滤,得注射液,将注射液瓶装封存,即得所述的治疗精神分裂症的中药制剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610128840.5A CN105663847A (zh) | 2016-02-29 | 2016-02-29 | 一种治疗精神分裂症的中药制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610128840.5A CN105663847A (zh) | 2016-02-29 | 2016-02-29 | 一种治疗精神分裂症的中药制剂及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105663847A true CN105663847A (zh) | 2016-06-15 |
Family
ID=56308022
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610128840.5A Withdrawn CN105663847A (zh) | 2016-02-29 | 2016-02-29 | 一种治疗精神分裂症的中药制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105663847A (zh) |
-
2016
- 2016-02-29 CN CN201610128840.5A patent/CN105663847A/zh not_active Withdrawn
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103860941A (zh) | 一种治疗精神分裂症的中药及其制备方法 | |
CN103520505B (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN107913370A (zh) | 一种中西医结合治疗酒精性肝病的药物及制备方法 | |
CN104306678A (zh) | 一种治疗产后抑郁的中药制剂及制备方法 | |
CN102266435B (zh) | 一种专治牛皮癣的中药 | |
CN103751627B (zh) | 一种治疗神经衰弱的中药制剂及制备方法 | |
CN106377717A (zh) | 一种可有效治疗儿童智力低下的中药组合物及其制备方法 | |
CN103845626B (zh) | 一种治疗精神分裂症的药物及制备方法 | |
CN105663847A (zh) | 一种治疗精神分裂症的中药制剂及制备方法 | |
CN104547384A (zh) | 一种治疗百草枯中毒的口服液及制备方法 | |
CN103751624B (zh) | 一种治疗中风后肢体麻木的药物及制备方法 | |
CN104117020A (zh) | 一种治疗心房颤动的中药配方 | |
CN103830649B (zh) | 一种治疗慢性酒精中毒的药物及其制备方法 | |
CN103610916B (zh) | 一种治疗动脉硬化的中药制剂 | |
CN104225238A (zh) | 一种治疗糖尿病的中药组合物 | |
CN104225340A (zh) | 一种治疗白血病的药物及制备方法 | |
CN105943639A (zh) | 一种辅助治疗慢性硬脑膜下血肿的中药组合物 | |
CN105770759A (zh) | 一种治疗阑尾炎的中药 | |
CN104825735A (zh) | 补肾保健药酒 | |
CN105213975A (zh) | 一种治疗肝硬化的药物组合物及其应用 | |
CN104547447A (zh) | 一种治疗麻醉药不良反应的中药药水及制备方法 | |
CN104784588A (zh) | 一种用于治疗神经性头痛的中药制剂及制备方法 | |
CN104173808B (zh) | 一种治疗肝火上炎型高血压的中药及其制备方法 | |
CN103893308B (zh) | 一种治疗腹部疼痛的中药热敷膏及制备方法 | |
CN104645102A (zh) | 一种治疗食道炎的中药制剂及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 510515 Southern Medical University, 1063, Sha Tai Road, Baiyun District, Guangzhou, Guangdong Applicant after: Xu Chonglan Address before: 276826 Shandong Rizhao City Donggang District South Lake Town West Ming Zhao Village Applicant before: Xu Chonglan |
|
WW01 | Invention patent application withdrawn after publication | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20160615 |